Sign In
Buy EGRX
$0.460
+0 (+0%)
At Close: Jun 03, 2026
Teva Reports First Quarter 2020 Financial Results
12:00am, Thursday, 07'th May 2020
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended March 31, 2020. Mr. Kåre Schultz, Teva's Pre
3 Promising Biotech Stocks to Buy on a Market Pullback
02:00pm, Monday, 04'th May 2020
Eagle Pharmaceuticals, Biohaven Pharmaceuticals and Acadia Pharmaceuticals are names to consider on a 10% move down in equities.
Eagle Pharma Says it Plans to Request a Meeting with the FDA to Advance its EA-114 Program
10:53am, Monday, 04'th May 2020
Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company") (NASDAQ: EGRX) today provided an update on its pilot clinical study to assess the unique characteristics of its fulvestrant product candidate, EA
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today provided an update on its pilot clinical study to assess the unique charac
Chartwell Investment Partners LLC Buys 3,595 Shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
10:04am, Saturday, 02'nd May 2020
Chartwell Investment Partners LLC increased its stake in Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 1.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm o
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX), Biogen (BIIB) and Emergent Biosolutions
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX – Research
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and Dynavax (DVAX)
03:50pm, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioMarin Pharmaceutical (BMRN) and Dynavax (DVAX) with
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Dynavax (NASDAQ: DVAX)
03:50pm, Friday, 01'st May 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioMarin Pharmaceutical (
BMRN
–
Research Report
) and Dynavax (
DVAX
–
Research Report
) with bull
Teva's Patent Win, And Other News: The Good, Bad And Ugly Of Biopharma
08:56am, Thursday, 30'th Apr 2020
Teva achieves another patent lawsuit victory. Merck's Keytruda gets another approval. Clearside's NDA submission is delayed.
Eagle Pharmaceuticals to Discuss First Quarter 2020 Financial Results on May 11, 2020
08:30pm, Wednesday, 29'th Apr 2020
Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company") (Nasdaq: EGRX) today announced that the Company will release its 2020 first quarter financial results on Monday, May 11, 2020, before the market
Eagle Pharmaceuticals Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
12:00am, Wednesday, 29'th Apr 2020Earnings Preview: Eagle Pharmaceuticals (EGRX) Q1 Earnings Expected to Decline
04:33pm, Tuesday, 28'th Apr 2020
Eagle Pharmaceuticals (EGRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Eagle Pharmaceuticals (EGRX) Q1 Earnings Expected to Decline
04:33pm, Tuesday, 28'th Apr 2020
Eagle Pharmaceuticals (EGRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
